LINEAGE CELL THERAPEUTICS IN (LCTX) Institutional Ownership Changes & 13F Activity

LINEAGE CELL THERAPEUTICS IN (LCTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, Armistice Capital, Llc, Marshall Wace, Llp, Susquehanna International Group, Llp, and Citadel Advisors Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Western Wealth Management, LlcBuy+300—300$474.00Q1 2026May 19, 2026
Bank Of America CorpBuy+221,506+112.0%419,355$662.58KQ1 2026May 18, 2026
Sunbelt Securities, Inc.Buy+2,000—2,000$3.16KQ1 2026May 18, 2026
Millennium Management LlcBuy+3,450,955+163.5%5,561,374$8.79MQ1 2026May 15, 2026
Armistice Capital, LlcBuy+3,182,799—3,182,799$5.03MQ1 2026May 15, 2026
Marshall Wace, LlpBuy+1,702,972+125.0%3,065,033$4.84MQ1 2026May 15, 2026
Susquehanna International Group, LlpBuy+598,270+84.7%1,304,685$2.06MQ1 2026May 15, 2026
Citadel Advisors LlcSell-376,104-74.2%130,948$206.90KQ1 2026May 15, 2026
Goldman Sachs Group IncSell-269,319-18.7%1,169,427$1.85MQ1 2026May 15, 2026
Brevan Howard Capital Management LpBuy+186,794—186,794$295.13KQ1 2026May 15, 2026
Two Sigma Investments, LpSell-177,000-66.6%88,585$139.96KQ1 2026May 15, 2026
Omers Administration CorpSell-174,200-61.5%109,000$172.22KQ1 2026May 15, 2026
Point72 Asset Management, L.P.Buy+144,955+90.9%304,363$480.89KQ1 2026May 15, 2026
Morgan StanleySell-130,172-6.5%1,868,491$2.95MQ1 2026May 15, 2026
Jain Global LlcBuy+83,200+214.2%122,051$192.84KQ1 2026May 15, 2026
Squarepoint Ops LlcBuy+78,081+119.9%143,190$226.24KQ1 2026May 15, 2026
State Street CorpBuy+73,900+7.3%1,090,111$1.72MQ1 2026May 15, 2026
Geode Capital Management, LlcBuy+61,921+2.5%2,523,114$3.99MQ1 2026May 15, 2026
Diametric Capital, LpBuy+59,029—59,029$93.27KQ1 2026May 15, 2026
Qube Research & Technologies LtdBuy+48,213+22.8%259,561$410.11KQ1 2026May 15, 2026
Barclays PlcBuy+44,799+12.9%393,309$621.43KQ1 2026May 15, 2026
Summittx Capital, L.P.Buy+39,514+185.3%60,833$96.12KQ1 2026May 15, 2026
Schonfeld Strategic Advisors LlcBuy+34,699+260.5%48,017$75.87KQ1 2026May 15, 2026
Lmr Partners LlpBuy+21,160—21,160$33.43KQ1 2026May 15, 2026
Quantessence Capital LlcBuy+16,281—16,281$25.72KQ1 2026May 15, 2026
Prelude Capital Management, LlcBuy+14,942—14,942$23.61KQ1 2026May 15, 2026
Voleon Capital Management LpBuy+14,771+20.8%85,739$135.47KQ1 2026May 15, 2026
Xtx Topco LtdSell-9,913-23.4%32,368$51.14KQ1 2026May 15, 2026
Tower Research Capital Llc (Trc)Buy+3,716+19.1%23,187$36.63KQ1 2026May 15, 2026
Two Sigma Securities, LlcSell-3,208-13.6%20,390$32.22KQ1 2026May 15, 2026
Showing 30 of 100

Frequently asked questions about LCTX activity

  • Which institutional owners are buying LCTX?

    Institutional owners buying LCTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in LCTX activity?

    "Buy" means an investor increased their reported position in LCTX compared to the prior reporting period. This reflects growing exposure to LINEAGE CELL THERAPEUTICS IN (LCTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in LCTX increasing?

    Institutional interest in LCTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.